what are the most popular glp 1 drugs Market Overview: GLP-1 Agonists and Obesity Market | Blog Comparing Ozempic, Wegovy and Other
Description
How does phentermine work
Efpeglenatide: The AMPLITUDE-O trial (2021) demonstrated a 27% MACE reduction (HR 0.73, 95% CI 0.580.92) in 4076 T2DM patients, with significant reductions in stroke and HF events [19]
DPP-4 inhibitors were not included in the two tiers because their effectiveness on glycemic control is lower than or equivalent to first- and second-tier agents, as well as for less clinical evidence and relative expense
AM: I love that
Endocrinology 137, 29682978
